Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Bristol Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" at Barclays
Barclays has upgraded Bristol Myers Squibb (NYSE:BMY) to a “strong-buy” rating, joining other firms that have recently raised their ratings or price targets for the biopharmaceutical company. Despite a recent earnings per share miss, the company’s revenue beat expectations and its positive pipeline, strategic factors, and 2026 guidance support a favorable medium-term outlook. However, recent downward revisions to near-term EPS estimates introduce some caution for short-term upside.